about
Multiple endocrine neoplasia type 2Familial syndromes associated with neuroendocrine tumoursMultiple endocrine neoplasia type 2: an overviewComputational modeling of structurally conserved cancer mutations in the RET and MET kinases: the impact on protein structure, dynamics, and stability.MEK inhibitor PD0325901 significantly reduces the growth of papillary thyroid carcinoma cells in vitro and in vivoSingle nucleotide polymorphism rs17849071 G/T in the PIK3CA gene is inversely associated with follicular thyroid cancer and PIK3CA amplification.Activation of the Erk8 mitogen-activated protein (MAP) kinase by RET/PTC3, a constitutively active form of the RET proto-oncogene.BAY 43-9006 inhibition of oncogenic RET mutants.Vitamin D receptor, an important transcription factor associated with aldosterone-producing adenoma.Solution structure and biophysical characterization of the multifaceted signalling effector protein growth arrest specific-1.The dependence receptor Ret induces apoptosis in somatotrophs through a Pit-1/p53 pathway, preventing tumor growth.Pathophysiology of ageing, longevity and age related diseasesMolecular genetics of multiple endocrine neoplasia types 1 and 2.Overexpression of MAPK15 in gastric cancer is associated with copy number gain and contributes to the stability of c-Jun.New perspectives on the treatment of differentiated thyroid cancer.What is New on Thyroid Cancer Biomarkers2012 European thyroid association guidelines for genetic testing and its clinical consequences in medullary thyroid cancerNeurotrophin selectivity in organizing topographic regeneration of nociceptive afferents.Ret function in muscle stem cells points to tyrosine kinase inhibitor therapy for facioscapulohumeral muscular dystrophy.Differences in the transcriptome of medullary thyroid cancer regarding the status and type of RET gene mutations.Medullary thyroid carcinoma: a 25-year perspective.Thyroid Cancer: Role of RET and Beyond.Characterization of aberrant melting peaks in unlabeled probe assaysAcute myeloid leukemia with translocation (8;16)(p11;p13) and MYST3-CREBBP rearrangement harbors a distinctive microRNA signature targeting RET proto-oncogene.The "next-generation" knowledge of papillary thyroid carcinomaCabozantinib for the treatment of non-small cell lung cancer with KIF5B-RET fusion. An example of swift repositioning.The RET E616Q Variant is a Gain of Function Mutation Present in a Family with Features of Multiple Endocrine Neoplasia 2A.Overexpression of genes involved in miRNA biogenesis in medullary thyroid carcinomas with RET mutation.Notch pathway is activated by MAPK signaling and influences papillary thyroid cancer proliferation.Combination of RET siRNA and irinotecan inhibited the growth of medullary thyroid carcinoma TT cells and xenografts via apoptosis.Human medullary thyroid carcinoma: a source and potential target for relaxin-like hormones.Value of routine measurement of serum calcitonin concentrations in patients with nodular thyroid disease: A multicenter study.[Iodothyronine deiodinases expression in thyroid neoplasias].New approaches for breast cancer: should Ret kinase be considered as a novel therapeutic target?GFRA1: A Novel Molecular Target for the Prevention of Osteosarcoma Chemoresistance.Diversity of mutations in the RET proto-oncogene and its oncogenic mechanism in medullary thyroid cancer.Pathogenesis of differentiated thyroid cancer (papillary and follicular)
P2860
Q21203027-220ADD68-3BF1-4ED6-9C26-5E31C40B9052Q26777791-26E4C2D1-865E-4843-8087-588A374F91D1Q28237010-A771D28A-D931-4713-9FEA-5CAD5E078C7EQ30374663-A48997EE-98C0-4043-A9C9-F0EC9C646E0FQ34109756-C1B9B050-5B68-4E21-BC59-9D90DC6BE14DQ34489924-9F2E8F7D-1F2D-48BF-9EF6-3B34B9E63AC9Q34495337-6E250B73-067D-4B59-8BFE-CA1E34160EB3Q34565246-975052E3-9892-435C-9FD3-6575CA49FE37Q35077564-7A79E9BD-0599-46C1-A795-574E7DD03AF8Q35147289-1DC5805D-E69D-4176-9A28-6A8316F9AB8FQ35752727-3AAFC521-B93E-4204-98AD-2E631A2CF17AQ35985777-D6B5840D-CA25-4806-BC08-DD977521C3ECQ36111935-62B136DD-2CC9-4C6E-8C37-76EF35CACD95Q36299630-67240E34-84EB-4544-A417-0AB203B083B0Q36904500-CB864D9D-41AC-4CD0-909B-592A838B9145Q37207279-8F2A0B62-CC36-416B-B7CF-F6E7139D262BQ37290956-F59DD853-C509-49DE-B7F4-70FC93FDB185Q37387436-7F2DD9F8-AE9D-46AE-945B-72AEF367174BQ37413081-BA9A2447-18AF-4D7F-B90E-02046B2286CBQ37633558-C40E15B7-8149-4AC1-BEF8-DE790D3ECF66Q38171726-18AA0539-7580-4328-B0D0-52403B60436DQ38208316-63D2D45C-2369-4DC5-AB8F-4922A7D0FB42Q38300546-0C38B607-7448-43D7-9DB1-A6889B92017EQ38321235-8321B095-DC11-4B82-8871-BDE06F223BE2Q38510649-3BE8646B-652D-45A5-93CE-D9E6A791E0A9Q38588103-C8072805-5F44-45E3-A773-B077C4655B4AQ38814755-32905189-D5AB-4ACC-B506-6C75A83E45A1Q39020838-B7781B6B-4BB7-4534-AFF0-7728922DB79CQ39173154-812A5671-EBA4-43ED-9AC9-B4B3B9E8C767Q39668289-4FE46B05-F952-485F-A557-664C7B01342FQ40409491-C06F6B8C-B7CE-431A-804A-715E00EA239FQ42497308-83079D64-C484-4110-8524-75D66457EA5DQ46985015-8559B538-D9CF-414C-BDA0-929FF8757B81Q48986806-A9F9F5EA-AB87-4F51-BF20-4F53D546B770Q52607614-1B6A5715-292C-4B20-B245-46C88C3015C6Q53368705-CB06B26F-5E0C-448E-8187-A69B0310A164Q56568567-6A2E7676-CCA4-4A41-ADB0-77F3DBEE30DD
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Minireview: RET: normal and abnormal functions
@ast
Minireview: RET: normal and abnormal functions
@en
Minireview: RET: normal and abnormal functions
@nl
type
label
Minireview: RET: normal and abnormal functions
@ast
Minireview: RET: normal and abnormal functions
@en
Minireview: RET: normal and abnormal functions
@nl
prefLabel
Minireview: RET: normal and abnormal functions
@ast
Minireview: RET: normal and abnormal functions
@en
Minireview: RET: normal and abnormal functions
@nl
P2093
P3181
P356
P1433
P1476
Minireview: RET: normal and abnormal functions
@en
P2093
Alfredo Fusco
Francesca Carlomagno
Giancarlo Vecchio
Massimo Santoro
Rosa Marina Melillo
P304
P3181
P356
10.1210/EN.2004-0922
P407
P577
2004-12-01T00:00:00Z